Earlier, solution small angle X-ray scattering (SAXS) data at 10 °C showed that soluble CD4 (sCD4; 1 mg/ml) is monomer with shape similar to single chain in crystal structures of its dimer. Query remained whether the dimeric state of CD4 can form independent of packing effects of crystal? Taking cue from other systems, we explored heat induced possible association of native shapes of sCD4 by variable temperature SAXS (VTSAXS) experiments. The predominant particle size increased consistently with temperature and around 35-40 °C, the estimated mass indicated dimeric state in solution. Furthermore, the observed association was found to be reversible to certain extent. Using SAXS profile representing dimer and crystal structure of monomer, we solved models of CD4 dimers which were dominated by D4-D4 interactions and appeared "wobbling" about the crystal structure of dimeric CD4, convincing pre-existence of crystal-like association in solution. To break the dimerization, we theoretically screened for small molecules binding to dimeric interface of D4 domain. Additionally, as negative control or not expecting to interfere, we searched molecules preferentially docking on the apex of D1 domain. VTSAXS experiments of CD4 + molecules at ∼1:3 molar ratio showed that as expected few D4 reactive hits could retard dimerization, yet surprisingly molecules which docked at D1 domain could also derail dimerization. Additional analysis led to conclusion that there lies a systematic communication network across the structural length of sCD4 which senses binding to self and other molecules, and our work can be used to develop new (or re-purpose known) molecules as CD4-reactive immunosuppressive agents.Communicated by Ramaswamy H. Sarma.

Download full-text PDF

Source
http://dx.doi.org/10.1080/07391102.2020.1771422DOI Listing

Publication Analysis

Top Keywords

soluble cd4
8
dimeric state
8
vtsaxs experiments
8
crystal structure
8
molecules
6
cd4
5
monomeric human
4
human soluble
4
cd4 dimerizes
4
dimerizes physiological
4

Similar Publications

Eliciting broadly neutralizing antibodies that protect against diverse HIV-1 strains is a primary goal of AIDS vaccine research. We characterized Ab1456 and Ab1271, two heterologously-neutralizing antibodies elicited in non-human primates by priming with an engineered V3-targeting SOSIP Env immunogen and boosting with increasingly native-like SOSIP Envs derived from different strain backgrounds. Structures of Env trimers in complex with these antibodies revealed V3 targeting, but on conformational states of Env distinct from the typical closed, prefusion trimeric SOSIP structure.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on HIV-1 envelope glycoproteins (Envs), which usually exist in a closed form, making it challenging to access their internal structures, crucial for designing vaccines that elicit broadly neutralizing antibodies (bnAbs).* -
  • Researchers discovered that 6 out of 13 transmitted/founder (T/F) HIV-1 strains showed incompletely closed Env conformations that allow better access to internal epitopes, indicating potential targets for more effective immunogen designs.* -
  • Using advanced cryo-electron microscopy, the team revealed structural movements in these incompletely closed Envs and demonstrated that a specific bnAb, N6, is effective against various Env forms, enhancing its antiviral efficacy against resistant
View Article and Find Full Text PDF
Article Synopsis
  • The HIV envelope glycoprotein (Env) is crucial for viral binding and immune responses but is difficult to target due to its complex structure and variability.
  • Flow virometry (FV) allows researchers to study HIV virions at the single-particle level using a range of monoclonal antibodies, demonstrating its effectiveness in characterizing Env.
  • The study highlights that both the production method of the virus and the addition of soluble CD4 can significantly influence the detection and conformation of Env on HIV virions.
View Article and Find Full Text PDF

Unlabelled: The envelope glycoprotein (Env) trimer on the surface of human immunodeficiency virus type I (HIV-1) mediates viral entry into host CD4 T cells and is the sole target of neutralizing antibodies. Broadly neutralizing antibodies (bnAbs) that target gp120 V3-glycan of HIV-1 Env trimer are potent and block the entry of diverse HIV-1 strains. Most V3-glycan bnAbs interact, to a different extent, with a glycan attached to N332, but Asn at this position is not absolutely conserved or required for HIV-1 entry based on the prevalence of N332 in different circulating HIV-1 strains from diverse clades.

View Article and Find Full Text PDF

The human immunodeficiency virus (HIV-1) envelope (Env) glycoprotein precursor (gp160) trimerizes, is modified by high-mannose glycans in the endoplasmic reticulum, and is transported via Golgi and non-Golgi secretory pathways to the infected cell surface. In the Golgi, gp160 is partially modified by complex carbohydrates and proteolytically cleaved to produce the mature functional Env trimer, which is preferentially incorporated into virions. Broadly neutralizing antibodies (bNAbs) generally recognize the cleaved Env trimer, whereas poorly neutralizing antibodies (pNAbs) bind the conformationally flexible gp160.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!